90 related articles for article (PubMed ID: 27175968)
1. MicroRNA‑126 is downregulated in thyroid cancer cells, and regulates proliferation, migration and invasion by targeting CXCR4.
Qian Y; Wang X; Lv Z; Guo C; Yang Y; Zhang J; Wang X
Mol Med Rep; 2016 Jul; 14(1):453-9. PubMed ID: 27175968
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.
Zhang GM; Luo L; Ding XM; Dong DH; Li B; Ma XC; Sun LJ
Mol Med Rep; 2016 Jun; 13(6):5029-2036. PubMed ID: 27108693
[TBL] [Abstract][Full Text] [Related]
3. microRNA-7 regulates cell growth, migration and invasion via direct targeting of PAK1 in thyroid cancer.
Yue K; Wang X; Wu Y; Zhou X; He Q; Duan Y
Mol Med Rep; 2016 Sep; 14(3):2127-34. PubMed ID: 27430434
[TBL] [Abstract][Full Text] [Related]
4. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of microRNA-497 in human osteosarcoma.
Liu Q; Wang H; Singh A; Shou F
Mol Med Rep; 2016 Jul; 14(1):439-45. PubMed ID: 27176490
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer.
Song L; Xie X; Yu S; Peng F; Peng L
Mol Med Rep; 2016 Feb; 13(2):1204-10. PubMed ID: 26677064
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-610 is downregulated in glioma cells, and inhibits proliferation and motility by directly targeting MDM2.
Yan Y; Peng Y; Ou Y; Jiang Y
Mol Med Rep; 2016 Sep; 14(3):2657-64. PubMed ID: 27485527
[TBL] [Abstract][Full Text] [Related]
8. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-320 was downregulated in non-small cell lung cancer and inhibited cell proliferation, migration and invasion by targeting fatty acid synthase.
Lei T; Zhu Y; Jiang C; Wang Y; Fu J; Fan Z; Qin H
Mol Med Rep; 2016 Aug; 14(2):1255-62. PubMed ID: 27277534
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-126/stromal cell-derived factor 1/C-X-C chemokine receptor type 7 signaling pathway promotes post-stroke angiogenesis of endothelial progenitor cell transplantation.
Shan C; Ma Y
Mol Med Rep; 2018 Apr; 17(4):5300-5305. PubMed ID: 29393458
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑126 suppresses the proliferation and migration of endothelial cells in experimental diabetic retinopathy by targeting polo‑like kinase 4.
Zheng Y; Liu Y; Wang L; Xu H; Lu Z; Xuan Y; Meng W; Ye L; Fang D; Zhou Y; Ke K; Liu Y; An M
Int J Mol Med; 2021 Jan; 47(1):151-160. PubMed ID: 33416109
[TBL] [Abstract][Full Text] [Related]
12. MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha.
Leone V; D'Angelo D; Rubio I; de Freitas PM; Federico A; Colamaio M; Pallante P; Medeiros-Neto G; Fusco A
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1388-98. PubMed ID: 21752897
[TBL] [Abstract][Full Text] [Related]
13. Effects of miR-27a upregulation on thyroid cancer cells migration, invasion, and angiogenesis.
Wang YL; Gong WG; Yuan QL
Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002594
[TBL] [Abstract][Full Text] [Related]
14. microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
Wu D; Pan H; Zhou Y; Zhou J; Fan Y; Qu P
Mol Med Rep; 2014 Jun; 9(6):2491-8. PubMed ID: 24714873
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-592 suppresses the malignant phenotypes of thyroid cancer by regulating lncRNA NEAT1 and downregulating NOVA1.
Luo Y; Hao T; Zhang J; Zhang M; Sun P; Wu L
Int J Mol Med; 2019 Sep; 44(3):1172-1182. PubMed ID: 31524231
[TBL] [Abstract][Full Text] [Related]
16. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-133a inhibits cell proliferation, colony formation ability, migration and invasion by targeting matrix metallopeptidase 9 in hepatocellular carcinoma.
Chen X; Bo L; Zhao X; Chen Q
Mol Med Rep; 2015 May; 11(5):3900-7. PubMed ID: 25607810
[TBL] [Abstract][Full Text] [Related]
18. miR-132 Targets FOXA1 and Exerts Tumor-Suppressing Functions in Thyroid Cancer.
Chen X; Li M; Zhou H; Zhang L
Oncol Res; 2019 Mar; 27(4):431-437. PubMed ID: 29523221
[TBL] [Abstract][Full Text] [Related]
19. MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer.
Wu ZY; Wang SM; Chen ZH; Huv SX; Huang K; Huang BJ; Du JL; Huang CM; Peng L; Jian ZX; Zhao G
Cancer Biomark; 2015; 15(5):535-42. PubMed ID: 26406941
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
Qin X; Wan Y; Wang S; Xue M
Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
